Literature DB >> 9466581

Glucocorticoid dynamics and impaired wound healing in diabetes mellitus.

M S Bitar1.   

Abstract

The aim of the present study was to examine corticosterone dynamics and its role in the pathogenesis of impaired wound healing in diabetes mellitus (DM). The streptozotocin-treated rat was used as an animal model for type I DM. A linear skin incision and subcutaneously implanted polyvinyl alcohol sponge disks were considered as wound-healing models. The data regarding corticosterone dynamics revealed diabetes-related increments in plasma corticosterone concentrations at various time intervals during the diurnal cycle (9:00 a.m., 12:00 noon, and 3:00 p.m.) Moreover, a reduction in the levels of hippocampal glucocorticoid receptors was also evident in this disease state. Immobilization-induced stress elevated plasma corticosterone levels in both control and 30-day diabetic rats. Although the diabetic rat seems capable of appropriately initiating a corticosterone stress response, it is dramatically impaired in its capacity to terminate it. A progressive decrease in collagen deposition on polyvinyl alcohol sponge and wounded skin tensile strength was seen as a function of the duration of diabetes. Similarly, polyvinyl alcohol sponges retrieved from 30-day diabetic rats also showed a marked reduction in the expression of mRNA transcripts for type I and type III collagen. A simulation of the impairment in wound-healing potential in DM was achieved by treating control animals with a supraphysiological dose of hydrocortisone. It is worthy of note that an endocrinological paradigm involving adrenalectomy and replacement therapy with hydrocortisone significantly improved the wound-related parameters, including collagen metabolism and wounded skin tensile strength in the streptozotocin diabetic rats. Overall, our data provide evidence that the diabetic state is associated with hypercortisolemia and that this phenomenon may contribute to impaired wound healing in DM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466581      PMCID: PMC1857956     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  Studies of wound healing in experimental diabetes mellitus.

Authors:  W H Goodson; T K Hung
Journal:  J Surg Res       Date:  1977-03       Impact factor: 2.192

2.  Loss of circadian rhythm in sleep-wakefulness cycle in the rat by suprachiasmatic nucleus lesions.

Authors:  N Ibuka; H Kawamura
Journal:  Brain Res       Date:  1975-10-10       Impact factor: 3.252

3.  Abnormal regulation of adrenal function in rats with streptozotocin diabetes.

Authors:  A F De Nicola; O Fridman; E J Del Castillo; V G Foglia
Journal:  Horm Metab Res       Date:  1977-11       Impact factor: 2.936

4.  Suprachiasmatic nuclear lesions do not abolish food-shifted circadian adrenal and temperature rhythmicity.

Authors:  D T Krieger; H Hauser; L C Krey
Journal:  Science       Date:  1977-07-22       Impact factor: 47.728

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

6.  Corticosterone binding to hippocampus: immediate and delayed influences of the absence of adrenal secretion.

Authors:  B S McEwen; G Wallach; C Magnus
Journal:  Brain Res       Date:  1974-04-19       Impact factor: 3.252

7.  Studies in wound healing in experimental diabetes.

Authors:  A Prakash; P N Pandit; L K Sharman
Journal:  Int Surg       Date:  1974-01

8.  Effect of vitamin A on reversing the inhibitory effect of cortisone on healing of open wounds in animals and man.

Authors:  T K Hunt; H P Ehrlich; J A Garcia; J E Dunphy
Journal:  Ann Surg       Date:  1969-10       Impact factor: 12.969

9.  Participation of the dorsal hippocampus in the glucocorticoid feedback effect on adrenocortical activity.

Authors:  S Feldman; N Conforti
Journal:  Neuroendocrinology       Date:  1980       Impact factor: 4.914

10.  Wound healing and the diabetic patient.

Authors:  W H Goodson; T K Hunt
Journal:  Surg Gynecol Obstet       Date:  1979-10
View more
  10 in total

1.  Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.

Authors:  Ana Tiganescu; Melanie Hupe; Yoshikazu Uchida; Theadora Mauro; Peter M Elias; Walter M Holleran
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

2.  Negative pressure wound therapy accelerates rats diabetic wound by promoting agenesis.

Authors:  Xiaoqiang Li; Jiaqi Liu; Yang Liu; Xiaolong Hu; Maolong Dong; Hongtao Wang; Dahai Hu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockade.

Authors:  Rashmi Kumari; Lisa B Willing; Leonard S Jefferson; Ian A Simpson; Scot R Kimball
Journal:  Biochem Biophys Res Commun       Date:  2011-08-11       Impact factor: 3.575

4.  Insulin prevents latent skin lesions by inhibiting the generation of advanced glycation end products in streptozotocin-induced diabetic rats.

Authors:  Xiangfang Chen; Weidong Lin; Shuliang Lu; Yongquan Shi; Junjie Zou; Zhimin Liu; Wanqing Liao
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

5.  Local blockade of glucocorticoid activation reverses stress- and glucocorticoid-induced delays in cutaneous wound healing.

Authors:  Jong-Kyung Youm; Kyungho Park; Yoshikazu Uchida; Aegean Chan; Theodora M Mauro; Walter M Holleran; Peter M Elias
Journal:  Wound Repair Regen       Date:  2013-08-08       Impact factor: 3.617

6.  Mechanical stretch and shear flow induced reorganization and recruitment of fibronectin in fibroblasts.

Authors:  Robert L Steward; Chao-Min Cheng; Jonathan D Ye; Robert M Bellin; Philip R LeDuc
Journal:  Sci Rep       Date:  2011-11-08       Impact factor: 4.379

7.  ROS constitute a convergence nexus in the development of IGF1 resistance and impaired wound healing in a rat model of type 2 diabetes.

Authors:  Milad S Bitar; Fahd Al-Mulla
Journal:  Dis Model Mech       Date:  2012-02-23       Impact factor: 5.758

8.  A soluble activin receptor type IIB does not improve blood glucose in streptozotocin-treated mice.

Authors:  Qian Wang; Tingqing Guo; Jennifer Portas; Alexandra C McPherron
Journal:  Int J Biol Sci       Date:  2015-01-05       Impact factor: 6.580

9.  Upregulation of CREM/ICER suppresses wound endothelial CRE-HIF-1α-VEGF-dependent signaling and impairs angiogenesis in type 2 diabetes.

Authors:  Milad S Bitar; Fahd Al-Mulla
Journal:  Dis Model Mech       Date:  2014-11-07       Impact factor: 5.758

10.  Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial.

Authors:  R A Ajjan; E M A Hensor; F Del Galdo; K Shams; A Abbas; R J Fairclough; L Webber; L Pegg; A Freeman; A E Taylor; W Arlt; A W Morgan; A A Tahrani; P M Stewart; D A Russell; A Tiganescu
Journal:  Eur J Endocrinol       Date:  2022-02-28       Impact factor: 6.664

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.